Avanti il prossimo

Riproduzione automatica

ALK mutations in paediatric tumours

4 Visualizzazioni • 07/30/23
Condividere
Incorporare
administrator
administrator
Iscritti
0

Dr Turner speaks with ecancer at Childhood Cancer 2016 about her work, made possible by a project grant from Children with Cancer UK.

She describes the role of ALK activity in the aetiology anaplastic large cell lymphoma, and as a target for paediatric therapies following the success of crizotinib in treating ALK lung cancer.

Considering the mechanisms of resistance, Dr Turner outlines how her research into screening for 'bypass tracks' might circumvent resistance in childhood disease.

Mostra di più
0 Commenti sort Ordina per
Commenti su Facebook

Avanti il prossimo

Riproduzione automatica